US HB2087 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on April 4 2019 - 25% progression, died in chamber
Action: 2019-05-21 - Subcommittee Hearings Held.
Text: Latest bill text (Introduced) [PDF]

Summary

Requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Drug Price Transparency Act

Sponsors


History

DateChamberAction
2019-05-21HouseSubcommittee Hearings Held.
2019-04-05HouseReferred to the Subcommittee on Health.
2019-04-04HouseReferred to the Subcommittee on Health.
2019-04-04HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-04HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-04HouseIntroduced in House

Same As/Similar To

HB2113 (Related) 2020-12-24 - Placed on the Union Calendar, Calendar No. 571.
SB2051 (Related) 2019-06-28 - Read twice and referred to the Committee on Finance.
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
HB1570 (Related) 2020-12-10 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback